News Headlines Article

The Unfinished Business Of Health Care Reform: Real Access To Innovative Medicines
Forbes

A year ago in this space, I wrote about the importance of adherence – patients taking prescribed medicines as directed. I cited an independent study by the IMS Institute for Healthcare Informatics, which estimated that non-adherence costs the U.S. health care system $105 billion each year.

Today, I want to address the unfulfilled promise of health care reform for many people with diabetes and cancer – as well as HIV/AIDS, Multiple Sclerosis, and other chronic diseases – that leaves them without real access to the medicines that can best meet their needs.

Commands